JRCT ID: jRCT1080220042
Registered date:06/09/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | ATL |
Date of first enrollment | 06/09/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Interferon gamma-nl INN of investigational material : Therapeutic category code : 639 Other biological preparations Dosage and Administration for Investigational material : IM |
Outcome(s)
Primary Outcome | Efficacy/safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 79age old |
Gender | Both |
Include criteria | Patients with ATL aged between 20 and 79 years, inclusive, at time of consent |
Exclude criteria |
Related Information
Primary Sponsor | Otsuka Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050042 |
Contact
Public contact | |
Name | |
Address | 03-6361-7314 |
Telephone | |
Affiliation | Otsuka Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |